Linagliptin increases incretin levels, lowers glucagon, and improves glycemic control in type 2 diabetes mellitus
{{output}}
Introduction: Linagliptin is a xanthine-based dipeptidyl peptidase (DPP)-4 inhibitor that is now available in numerous countries worldwide for the treatment of type 2 diabetes mellitus (T2DM). The aim of this study was to evaluat... ...
